Amgen Inc. logo AMGN - Amgen Inc.

NEXT EARNINGS: May 7, 2026
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 22
HOLD 11
SELL 3
STRONG
SELL
0
| PRICE TARGET: $364.09 DETAILS
HIGH: $425.00
LOW: $309.00
MEDIAN: $372.00
CONSENSUS: $364.09
DOWNSIDE: 0.72%
Market Cap: 197.48B
Volume: 3,402,610
Avg Volume: 2,907,959
52 Week Range: 261.43-368.5999
Sector: Healthcare
Industry: Drug Manufacturers - General
Beta: 0.47
Last Dividend: $9.52
Exchange: NASDAQ
Country: US
Employees: 28,000
IPO Date: 1983-06-17
EPS (TTM): 14.33
P/E Ratio: 22.84
Revenue (TTM): 36.75B
Total Assets: 90.59B
Total Debt: 54.60B
Cash & Equiv: 9.13B
Rev Growth (5Y): 7.6%
EPS Growth (5Y): 2.9%
FCF Growth (5Y): -3.9%
ROCE: 18.1%
Debt/Equity: 6.31

Track Record

Statements >
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 36.75B 33.42B 28.19B 26.32B 25.98B 25.42B 23.36B 23.75B 22.85B 22.99B 21.66B 20.06B
Net Income 7.71B 4.09B 6.72B 6.55B 5.89B 7.26B 7.84B 8.39B 1.98B 7.72B 6.94B 5.16B
EPS 14.33 7.62 12.56 12.18 10.34 12.40 12.96 12.70 2.71 10.32 9.15 6.80
Total Assets 90.59B 91.84B 97.15B 65.12B 61.16B 62.95B 59.71B 66.42B 79.95B 77.63B 71.58B 69.01B
Total Debt 54.60B 60.10B 64.61B 38.95B 33.31B 32.99B 29.90B 33.93B 35.34B 34.60B 31.43B 30.71B
Cash & Equivalents 9.13B 11.97B 10.94B 7.63B 7.99B 6.27B 6.04B 6.95B 3.80B 3.24B 4.14B 3.73B
Operating Cash Flow 9.96B 11.49B 8.47B 9.72B 9.26B 10.50B 9.15B 11.30B 11.18B 10.35B 9.08B 8.55B
Free Cash Flow 8.10B 10.39B 7.36B 8.79B 8.38B 9.89B 8.53B 10.56B 10.51B 9.52B 8.43B 7.55B
FCF per Share 15.06 19.21 13.76 16.33 14.70 16.88 14.10 15.97 14.38 12.72 11.12 9.95
Book Value 8.66B 5.88B 6.23B 3.66B 6.70B 9.41B 9.67B 12.50B 25.24B 29.88B 28.08B 25.78B
Cash & ST Investments 9.13B 11.97B 10.94B 9.30B 8.04B 10.65B 8.91B 29.30B 41.68B 38.09B 31.38B 27.03B
ROC Equity 0.89 0.70 1.08 1.79 0.88 0.77 0.81 0.67 0.08 0.26 0.25 0.20